Disclosure of Outside Interests for CAGT Investigators | BCM

Center for Cell and Gene Therapy

News

Master

Content

The following are current disclosure of outside interests for the Center for Cell and Gene Therapy investigators.

Content

Helen Heslop, M.D.

Interest	Company
Equity	Allovir Marker Therapeutics
Scientific Advisory Board	Gilead Biosciences Novartis Tessa Therapeutics Marker Therapeutics Kiadis PACT Pharma Mesoblast
Research Support	Tessa Therapeutics Kuur Therapeutics
Royalties	None
Spouse Disclosures	None
Other	None

Content

Malcolm Brenner, M.D., Ph.D.

Interest	Company
Equity	Allovir Marker Therapeutics Tessa Therapeutics
Scientific Advisory Board	Tessa Therapeutics Marker Therapeutics Allogene Walking Fish Kuur Turnstone Biologics Posedia Tscan Bluebird Bio Adaptimmune Therapeutics Adintus Onkimure Triumvira Immunologics Allogene Bellicum Pharmaceuticals Memgen, LLC Brooklyn Immunotherapeutics Coya Astrazeneca Pharmaceuticals
Research Support	None
Royalties	Takeda Bellicum
Spouse Disclosures	See Cliona Rooney
Other	None

Content

Bambi Grilley

Interest	Company
Equity	AlloVir, QBRegulatory LLC
Scientific Advisory Board
Research Support
Royalties	None
Spouse Disclosures	None
Other	QBRegulatory provides consulting services to AlloVir, Marker Therapeutics, Tessa Therapeutics, Lokon Pharma and Proxima Clinical Research

Content

Natalia Lapteva

Interest	Company
Equity	None
Scientific Advisory Board	None
Research Support	Tessa Therapeutics
Royalties	None
Spouse Disclosures	None
Other	Consultant for Tessa Therapeutics

Content

Carlos Ramos

Interest	Company
Equity	None
Scientific Advisory Board	Novartis
Research Support	Tessa Therapeutics Kuur Therapeutics
Royalties	None
Spouse disclosures	None
Other	None

Content

Cliona Rooney, Ph.D.

Interest	Company
Equity	Allovir Marker Therapeutics
Scientific Advisory Board	Tessa Therapeutics Marker Therapeutics Cell Genix
Research Support	Tessa Therapeutics
Royalties	Takeda Marker Allovir Bellicum
Spouse Disclosures	See Malcolm Brenner
Other	None